糖尿病老年患者的潜在过度治疗:来自德国全科医院的横截面研究的结果
Solveig Weise1, Christiane Oelschläger1, Susanne Unverzagt1
1Institute of General Practice and Family Medicine, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle, Saale, Germany.
The European journal of general practice
|February 18, 2025
概括
过度治疗影响了12%的2型糖尿病 (DM2) 的老年患者. 一般医生必须评估和减少老年人使用降血糖药物,以防止伤害.
科学领域:
- 老年病的医生 老年病的医生
- 内分泌学 在内分泌学.
- 一般实践 医学 医学
背景情况:
- 过度治疗2型糖尿病 (DM2) 的老年患者具有重大风险.
- 一般医生 (GPs) 在老年人DM2管理中发挥着至关重要的作用.
研究的目的:
- 分析德国一般实践中DM2老年患者的代谢控制和治疗模式.
- 为了确定这种人群中过度治疗和风险因素的流行率.
主要方法:
- 一项涉及德国46个一般实践的横截面研究.
- 从460名患有DM2的老年患者 (≥70岁) 收集的数据,包括HbA1c,糖尿病治疗和GP特征.
- 过度治疗定义为HbA1c<47.5 mmol/mol的降血糖药物,加上80岁或以上的年龄或养老院居住.
主要成果:
- 在患有DM2的老年患者中,有12%的患者经历过度治疗,24%的患者有风险.
- 过度处理与城市居住有关 (OR 2.17).
- 女性患者的风险较低 (OR为0.59),并且观察到治疗中的实践水平显著变化.
结论:
- 过度治疗是患有DM2的老年患者的一个重要问题,需要定期的GP检查和处方.
- 糖尿病管理的一般实践之间的异质性凸显了对标准化监测和治疗方案的需求.
相关概念视频
Diabetes: Management and Pharmacotherapy
229
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
229
Diabetes: Symptoms, Diagnosis, and Complications
498
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
498
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
158
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
158
Hypoglycemia and Glucagon
149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149


